- Home
- JZ vs CRIS Comparison
JZ vs CRIS Comparison
Compare JZ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- CRIS
- Stock Information
- Founded
- JZ 2011
- CRIS 2000
- Country
- JZ China
- CRIS United States
- Employees
- JZ N/A
- CRIS N/A
- Industry
- JZ Other Consumer Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JZ Real Estate
- CRIS Health Care
- Exchange
- JZ Nasdaq
- CRIS Nasdaq
- Market Cap
- JZ 26.7M
- CRIS 21.3M
- IPO Year
- JZ 2022
- CRIS 2000
- Fundamental
- Price
- JZ $0.36
- CRIS $2.39
- Analyst Decision
- JZ
- CRIS Strong Buy
- Analyst Count
- JZ 0
- CRIS 2
- Target Price
- JZ N/A
- CRIS $16.50
- AVG Volume (30 Days)
- JZ 2.7M
- CRIS 78.6K
- Earning Date
- JZ 09-27-2024
- CRIS 07-31-2025
- Dividend Yield
- JZ N/A
- CRIS N/A
- EPS Growth
- JZ N/A
- CRIS N/A
- EPS
- JZ N/A
- CRIS N/A
- Revenue
- JZ $34,090,704.00
- CRIS $11,202,000.00
- Revenue This Year
- JZ N/A
- CRIS $0.93
- Revenue Next Year
- JZ N/A
- CRIS $8.10
- P/E Ratio
- JZ N/A
- CRIS N/A
- Revenue Growth
- JZ N/A
- CRIS 14.17
- 52 Week Low
- JZ $0.33
- CRIS $1.02
- 52 Week High
- JZ $1.76
- CRIS $9.78
- Technical
- Relative Strength Index (RSI)
- JZ 30.74
- CRIS 60.94
- Support Level
- JZ $0.34
- CRIS $2.23
- Resistance Level
- JZ $0.37
- CRIS $2.63
- Average True Range (ATR)
- JZ 0.03
- CRIS 0.18
- MACD
- JZ 0.01
- CRIS 0.03
- Stochastic Oscillator
- JZ 23.81
- CRIS 69.62
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.